obesity-995x60.png
FEATURED ARTICLES
Who Owns Your Clinical Trial Software When The Vendor Leaves?
When a clinical trial software vendor exits, sponsors still own the risk. Learn what to secure before signing a contract to protect data, validation, and continuity.
-
The Site Landscape Is Evolving, But How? Tufts CSDD Shares New Findings
Tufts CSDD data reveals how academic, independent, and network-affiliated clinical trial sites differ in growth, reach, staffing, and performance.
-
Testing Early Treatment In Head And Neck Cancer Without Compromising Curative Care
Can early APG-157 treatment control head and neck cancer without delaying curative care? A Phase 3 trial puts timing, safety, and outcomes to the test.
-
Founders, Fortitude, And Clinical Trials
After talking with six clinical trials-related company founders, I came away admiring the tenacity, fortitude, and curiosity it takes to turn an idea into a business — and keep it going through setbacks, uncertainty, and constant change.